The fibrinolytic system in patients with congenital protein C deficiency.
D000293:Adolescent; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000097:blood / Q000151:congenital* / Q000188:drug therapy; D001779:Blood Coagulation Factors / Q000032:analysis; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006023:Glycoproteins / Q000172:deficiency*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010958:Plasminogen / Q000032:analysis; D010960:Plasminogen Activators / Q000032:analysis; D011486:Protein C; D000979:alpha-2-Antiplasmin / Q000032:analysis
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D006023:Glycoproteins; D011486:Protein C; D000979:alpha-2-Antiplasmin; D010958:Plasminogen; D010960:Plasminogen Activators